Latest / Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Revefenacin Pharmacology Podcast
Revefenacin (brand name Yupelri) is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors, particularly the M3 subtype, in airway smooth muscle. This antagonism reduces cholinergic bronchoconstriction and leads to sustained bronchodilation. Unlike short-acting anticholinergics such as ipratropium, revefenacin provides 24-hour bronchodilation with once-daily dosing.
One of the distinguishing features of revefenacin is that it is the first nebulized LAMA approved for COPD…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.